Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

40.18
Delayed Data
As of Sep 20
 +0.26 / +0.65%
Today’s Change
37.20
Today|||52-Week Range
44.54
+4.34%
Year-to-Date

Today’s Trading

Previous close39.92
Today’s open39.94
Day’s range39.86 - 40.19
Volume4,008,280
Average volume (3 months)2,830,354
Market cap$98.2B
Dividend yield6.19%
Data as of 09/20/2017

Growth & Valuation

Earnings growth (last year)-90.48%
Earnings growth (this year)+15.23%
Earnings growth (next 5 years)+5.50%
Revenue growth (last year)+2.85%
P/E ratio51.0
Price/Sales2.52
Price/Book69.95

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.56+0.89%
NVONovo Nordisk+0.46+0.95%
LLYEli Lilly and Co+0.29+0.35%
CELGCelgene+0.77+0.54%
Data as of 09/20/2017

Financials

Next reporting dateOctober 25, 2017
EPS forecast (this quarter)$0.83
Annual revenue (last year)$37.5B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts